A study of recent inspection observations allows for baseline trending and continuous improvement. (The opinions expressed in this article do not necessarily reflect FDA’s position on the matter being discussed.)
Lisa Tung
Advertisement
Lisa has a PharmD. ad M.P.H, and is a consumer safety officer at FDA. She can be reached at [email protected].
Articles by Lisa Tung
Advertisement
Latest Updated Articles
Lessons Learned from FDA Inspections of Foreign API FacilitiesSeptember 8th 2015
Advertisement
Advertisement